Back to results
US 11,230,559 B2Granted
Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate
AssigneeHoffmann-La Roche Inc.
InventorsKatja Grosse-Sender, Urs Schwitter, Frank Stowasser, Xuemei Wang, Jing Xiong
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel solid forms of compound (I) [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate and pharmaceutical compositions comprising the solid forms thereof disclosed herein, which may be used as a TLR7 agonist, or for the treatment or prophylaxis of a viral disease in a patient relating to HBV infection or a disease caused by HBV infection.
Claims13
A solid form of compound (I),
- or a salt, or solvate, thereof, wherein the form is Form C, Form D, or Form E or a combination thereof.
Dependencies are inferred from the claim text.